Knowledge of HbA1c and LDL‐C treatment goals, subjective level of disease‐related information and information needs in patients with atherosclerotic cardiovascular disease

BACKGROUND/HYPOTHESIS: Risk factor control of diabetes mellitus (DM) and especially dyslipidemia remains unsatisfactory in patients with atherosclerotic cardiovascular disease (ASCVD). We aimed to analyze the knowledge of low‐density lipoprotein cholesterol (LDL‐C) and glycated hemoglobin (HbA1c) tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Brockmeyer, Maximilian, Wies, Emilia, Joerges, Jamuna, Sommer, Jana, Borgmann, Sandra Olivia, Chernyak, Nadja, Lin, Yingfeng, Parco, Claudio, Schulze, Volker, Heinen, Yvonne, Kelm, Malte, Icks, Andrea, Perings, Stefan, Wolff, Georg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Clinical Trial Result
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933116/
https://www.ncbi.nlm.nih.gov/pubmed/36448416
http://dx.doi.org/10.1002/clc.23948

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933116/
https://www.ncbi.nlm.nih.gov/pubmed/36448416
http://dx.doi.org/10.1002/clc.23948

Ejemplares similares